相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model
Fiona Y. Glassman et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher
Fiona Y. Glassman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity
Robin B. Hartholt et al.
BLOOD REVIEWS (2017)
Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
Jesse Lai et al.
BLOOD (2017)
Immunogenicity of long-lasting recombinant factor VIII products
Mathieu Ing et al.
CELLULAR IMMUNOLOGY (2016)
First preclinical support for the 'danger theory' in inhibitor development
L. F. D. van Vulpen et al.
HAEMOPHILIA (2016)
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
F. Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein
Charles L. Groomes et al.
PEDIATRIC BLOOD & CANCER (2016)
Soy Phosphatidylinositol Containing Nanoparticle Prolongs Hemostatic Activity of B-Domain Deleted Factor VIII in Hemophilia A Mice
Krithika A. Shetty et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4
Gregory T. Tietjen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Samantha C. Gouw et al.
BLOOD (2013)
Exposure to Factor VIII Protein in the Presence of Phosphatidylserine Induces Hypo-responsiveness toward Factor VIII Challenge in Hemophilia A Mice
Puneet Gaitonde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function
Puneet Gaitonde et al.
CLINICAL IMMUNOLOGY (2011)
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
A. Iorio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Phospholipid binding improves plasma survival of factor VIII
Dipak S. Pisal et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Treatment of hemophilia: a review of current advances and ongoing issues
Antonio Coppola et al.
JOURNAL OF BLOOD MEDICINE (2010)
How we treat a hemophilia A patient with a factor VIII inhibitor
Christine L. Kempton et al.
BLOOD (2009)
Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A
Karthik Ramani et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
J Goudemand et al.
BLOOD (2006)
Lipid binding region (2303-2332) is involved in aggregation of recombinant human FVIII (rFVIII)
K Ramani et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
分享论文
